Citius Oncology, Inc. (CTOR)
NASDAQ: CTOR · Real-Time Price · USD
0.995
-0.005 (-0.51%)
Nov 21, 2024, 11:45 AM EST - Market open
Citius Oncology Cash Flow Statement
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
| TTM
| FY 2023 | FY 2022 |
| Jun '24 Jun 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 |
| Net Income | -19.52 | -12.7 | -10.87 |
| Stock-Based Compensation | 7.8 | 1.97 | - |
| Other Operating Activities | 0.58 | 0.58 | 1.15 |
| Change in Accounts Payable | -1.27 | 1.2 | 0.18 |
| Change in Other Net Operating Assets | 12.42 | 8.96 | 9.53 |
| Levered Free Cash Flow | 7.11 | 4.55 | - |
| Unlevered Free Cash Flow | 7.11 | 4.55 | - |
| Change in Net Working Capital | -11.15 | -10.16 | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.